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ABSTRACT 
Carbapenemases involved in acquired carbapenem resistance in Enterobacteriaceae belong to 
Ambler class A serin β-lactamases, class B metallo-β-lactamases (MBL) or class D OXA-48-
like β-lactamases. The aim of the present study was to analyse the molecular epidemiology 
and the mechanisms and routes of spread of class B and class D carbapenemases in Croatia.  
In total 68 isolates were analyzed. Antibiotic susceptibility was determined by broth 
microdilution method. PCR was used to detect antibiotic-resistance genes. Genotyping was 
performed by rep-PCR and MLST. 
Sixty-five isolates were found to harbour VIM-1 carbapenemase, seven of which were 
positive also for NDM-1, while two strains harboured only NDM-1. OXA-48 was detected in 
three isolates, two of which coproduced VIM-1. Thirty-six strains possessed additional CTX-
M-15 β-lactamase whereas 64 were positive for TEM-1. CMY was found in 18 C. freundii 
isolates and DHA-1 in one E. cloacae isolate. Four different plasmid-incompatibility groups 
were found: A/C, L/M, N and FIIAs. Unlike C. freundii and E. cloacae, K. pneumoniae 
showed high diversity of rep-PCR patterns. E. cloacae and C. freundii predominantly 
belonged to one large clone which was allocated to ST105 and ST24, respectively.  
Three different types of carbapenemases were identified showing the complexity of CRE in 
Croatia.  
Key words: Enterobacteriaceae, VIM-1, NDM-1, OXA-48, carbapenems 
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1. Introduction 
 
Carbapenems are the drugs of choice for the treatment of infections caused by multiresistant 
Gram-negative bacilli (Queenan and Bush, 2007). Carbapenemases involved in acquired 
resistance to carbapenems in Enterobacteriaceae belong to Ambler class A serin β-lactamases 
(KPC, GES, SME, IMI, NMC), class B metallo-β-lactamases (MBL) of IMP, VIM or NDM 
family or OXA-48-like β-lactamases belonging to the class D (Canton et al., 2012). The class 
B enzymes are the most clinically important carbapenemases, because they are capable of 
hydrolyzing all β-lactam antibiotics except of aztreonam (Queenan and Bush, 2007).  
The first carbapenem–resistant Enterobacteria detected in Croatia was NDM-1 producing 
Klebsiella pneumoniae isolated in 2008 in the University Hospital Center Zagreb (Mazzariol 
et al., 2012). A remarkable increase in the number of carbapenem-resistant isolates was 
observed in 2012. This observation gave rise to a multicenter study on carbapenem-resistance 
in Enterobacteriaceae from Croatia, conducted in 2011 to 2012 which revealed the 
predominance of VIM-1 β-lactamase in two large hospital centers (Zujic-Atalic et al., 2014)). 
Two years later the clonal outbreak of VIM-1 positive Enterobacter cloacae and Citrobacter 
freundii at alarming rate was observed in the largest hospital center in Croatia and emergence 
of OXA-48 β-lactamase in Enterobacteriaceae was reported for the first time in two hospital 
centers in Croatia. This prompted us to analyse the epidemiology, the mechanisms of 
antibiotic resistance, and the routes of spread of class B and class D carbapenemases in 
Croatia.  
 
2. Material and methods 
2.1.Bacterial isolates 
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In total 68 non-duplicate isolates producing class B and D carbapenemase were analyzed: 34 
Enterobacter cloacae, 18 Citrobacter freundii, 15 Klebsiella pneumoniae and 1 Klebsiella 
oxytoca.  
Isolates were obtained from three hospital centers located in different geographic regions of 
Croatia (University Hospital Zagreb 60 isolates, University Hospital Split seven isolates and 
University Hospital Osijek one isolate) were analyzed. KPC positive strains and those with 
carbapenem non-susceptibility due to porin loss combined with ESBLs were not included in 
the study. KPC-positive isolates were included in another study. The strains were identified 
by Vitek2 (Biomerieux) and Maldi-TOFF (Bruker).  
Since 2012 surveillance system for detection of carbapenem-resistant Enterobacteriaceae 
from different regional hospitals including phenotypic and molecular detection of resistance 
genes has been established in University Hospital Center Zagreb.  
During the study period (2013-2014) in University Hospital Center Zagreb, decreased 
susceptibility to carbapenems was detected in 306 strains of Enterobacteriaceae belonging to 
four genera (out of 19938 in total). Sixty strains out of 306 produced class B and class D 
carbapenemases and all were subjected to molecular analysis. The rest of the strains produced 
KPC (class A) or had reduced susceptibility to carbapenems due to porin loss in combination 
with ESBL production and they were not the subject of the study. In University Hospital 
Center Split there were 86 isolates (out of 5610 in total) showing reduced susceptibility to 
carbapenems and belonging to three genera. In total, 29 strains (out of 86) were positive for 
class B and D β-lactamases, seven of which were subjected to molecular analysis.  
In University Hospital Osijek there was one carbapenem-resistant isolate in 2013. It produced 
class B carbapenemase. Data for 2014 are not available. In Children’s hospital there were no 
carbapenemase-producing isolates in 2013-2014. The total number of Enterobacteriaceae in 
Children’s Hospital during the study period was 2493.  
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2.2. Antimicrobial susceptibility testing and phenotypic tests for detection of ESBLs, plasmid-
mediated AmpC β-lactamases and carbapenemases 
The antimicrobial susceptibility to amoxicillin alone and combined with clavulanate, 
piperacillin/tazobactam, cefazoline, cefuroxime, ceftazidime, cefotaxime, ceftriaxone, 
cefepime, cefoxitin, imipenem, meropenem, gentamicin, ciprofloxacin and colistin was 
determined by disk-diffusion and broth microdilution method according to CLSI standardss 
(CLSI, 2012) and for colistin according to EUCAST standard (Http://www.eucast.org). The 
strains were classified as multidrug-resistant, extensively- drug resistant or pan- drug resistant 
(Magiorakis et al., 2012). 
Double disk synergy test (DDST) (Jarlier et al., 1988) and CLSI combined disk test with 
addition of clavulanic acid to cephalosporin disks were performed to detect ESBLs (CLSI, 
2012). Chromosomal or plasmid-mediated AmpC β-lactamases were detected by combined 
disk test using cephalosporin disks combined with PBA (3-aminophenylboronic acid 
(Coudron, 2005). Modified Hodge test (MHT) was used to screen for the production of 
carbapenemases (Lee et al., 2003). Additionally the isolates were tested by combined disk 
tests with imipenem and meropenem alone and combined with 3-aminophenylboronic acid 
test (PBA), 0.1 M EDTA or both to screen for KPC, MBLs, or simultaneous production of 
KPC and MBL, respectively (Pasteran et al 2009, Kim et al., 2007).  
2.3. Conjugation 
The transferability of ceftazidime resistance was determined by conjugation (broth mating 
method) at 35°C employing E. coli A15R- strain resistant to rifampicin and E. coli J65 
resistant to sodium azide (Elwell and Falkow, 1986).  
2.4. Molecular detection of resistance genes 
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The genes conferring resistance to β-lactams including broad spectrum and extended-
spectrum β-lactamases (blaSHV, blaTEM, blaCTX-M and blaPER-1) (Nuesch-Inderbinen et al., 
1996; Arlet et al., 1995; Woodford et al., 2004; Pagani et al., 2004; Woodford et al., 2006), 
plasmid-mediated AmpC β-lactamases (Perez-Perez and Hanson, 2002), class A  (blaKPC, 
blaSME, blaIMI, blaNMC,) and class B carbapenemases (blaVIM, blaIMP and blaNDM) and 
carbapenem hydrolyzing oxacillinases (blaOXA-48-like) (Poirel, et al, 2011) and to 
fluoroquinolones (qnrA, qnrB, qnrS) (Robiscek et al., 2006) were determined by PCR using 
protocols and conditions as described previously. PCR assays with primers 5’-CS and 3’-CS 
combined with forward and reverse primers for blaVIM were done to determine the location of 
blaVIM gene within class 1 integron (Jeong et al., 2003).  
2.5. Characterization of plasmids 
Plasmids were extracted from donor strains and their respective transconjugants with Qiagen 
Mini kit (Medical Intertrade, Zagreb, Croatia) according to the manufacturer’s instructions. 
After staining with ethidium bromide, the DNA was visualised by ultraviolet light [6].    
The sizes of the isolates' plasmids were estimated from the standard curve of migration 
distance versus logarithm (log10) of the molecular weight of four standard plasmids (148, 64, 
36 and 7 kb) from E. coli NTCC 50192. 
PCR-based replicon typing (PBRT) (Carattoli et al., 2005) was applied  to determine the 
plasmid content of the tested strains. Plasmid extractions obtained from transconjugant strains 
were subjected to PCR for detection of carbapenemases (MBL and OXA-48) and ESBLs in 
order to determine the location of bla genes and to PBRT to determine if the transconjugants 
harbour the same plasmid types as their respective donors.  
2.6. Genotyping 
Thirty-one E. cloacae, 16 C. freundii and 8 K. pneumoniae isolates were subjected to 
molecular typing by rep-PCR as described previously (Overdest et al, 2011).  
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The same strains were also genotyped by MLST according to Diancourt (Diancourt et al., 
2005). For C. freundii and E. clocacae analysis was done according to the website developed 
by Keith Jolley: (http://pubmlst.org/cfreundii/http://pubmlst.org/ecloacae/ 
  
3. RESULTS 
3.1. Patients and isolates 
The patients did not have travel history to the endemic areas. The clinical wards included in 
the study were: medical, haematology, urology, paediatric haematology, psyhiatrics, medical, 
surgical, and neurological intensive care unit (ICU), while two strains were obtained from 
outpatients previously treated in University Hospital Center Zagreb.  
3.2. Antimicrobial susceptibility testing and phenotypic tests for detection of β-lactamases 
All isolates were multidrug resistant according to Magiorakis et al since they displayed 
resistance to at least one antibiotic in three antimicrobial classes. The strains were uniformly 
resistant to amoxicillin alone and combined with clavulanic acid, cefazoline, ceftazidime, 
cefotaxime, ceftriaxone and cefoxitin and all but one (Enterobacter cloacae), susceptible to 
colistin as shown in Table 1a, b and c and Table 2. Amikacin was the second most active 
antibiotic with 35/67 (52%) susceptible strains. Only three (4%) strains were susceptible to 
imipenem and 1 (1%) to cefepime and meropenem according to CLSI. MICs of carbapenems 
ranged from susceptibility to frank resistance, depending on the strain. Heterogenous 
susceptibility was observed with ertapenem resistance and imipenem and meropenem being 
susceptible, intermediate or resistant.  The high resistance rates were noted also for 
ciprofloxacin (81%) and for gentamicin (84%).  There was no significant difference in 
resistance rates between different species as shown in Table 2.  
All strains were shown to be positive for carbapenemase production by Hodge test and all but 
one showed significant increase of the inhibition zone around carbapenems in the presence of 
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EDTA indicating the production of MBL. Sixty-three strains were phenotypically positive for 
ESBLs and only nine for AmpC as shown in Table 1.  
3.3. Transfer of resistance determinants 
Ceftazidime resistance was transferred to E. coli recipient resistant to sodium azide from 18 
C. freundii strains (66, 74, 88, 95, 116,  118, 195, 255, 273, 287, 335, 337, 347, 348, 355, 356, 
361 and 363) and 16  Klebsiella spp (strain number 67,73, 86, 87, 117, 174, 178, 216, 271, 
279, 289, 290, 301, 305 4524 and 1755) with the frequency ranging from 10-7 to 10-5.  
Enterobacter cloacae strains did not transfer ceftazidime resistance. Resistance to gentamicin, 
sulphametoxazole, tetracycline, cloramphenicol and fluoroquinolones was not cotransferred 
alongside with ceftazidime resistance.  
3.4. Characterization of β-lactamases and other resistance genes 
Sixty-five isolates were found to harbour VIM-1 carbapenemase, seven of which were 
positive for NDM-1 as well, while two strains harboured only NDM-1 (Table 1). OXA-48 
was detected in three isolates, two of which coproduced VIM-1. Thirty-six strains possessed 
additional CTX-M-15 ESBL whereas 64 were positive for TEM-1. CMY was found in 18 C. 
freundii isolates and DHA-1 in one E. cloacae isolate. NDM-1 β-lactamase was carried by six 
K. pneumoniae, two C. freundii and one E. cloacae isolate. All C. freundii strains produced 
either CMY-2 or CMY-4 and all but one TEM-1 as additional β-lactamases to MBL. blaOXA-48 
genes were carried by two identical E. cloacae strains from Zagreb and one K. pneumoniae 
from Split as shown in Tables 1a, 1b and 1c.  All except one K. pneumoniae strains were 
positive for SHV-1 while one produced SHV-11 which is also intrinsic chromosomal β-
lactamase of this species. Other species (E. cloacae and C. freundii) were negative for SHV β-
lactamases. Two K. pneumoniae strains tested positive for AmpC in phenotypic tests but 
failed to yield PCR product with primers specific for AmpC β-lactamases. 
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C. freundii transconjugant strains were positive for blaVIM genes and blaNDM genes as their 
respective donors while blaOXA-48 gene was found in one K. pneumoniae transconjugant.  
blaVIM-1 genes were embedded in class 1 integrons which contained integrase gene followed 
by blaVIM-1 and aminoglycoside resistance determinant aadA1. The same integron content was 
found in different strain genera. 
QnrB determinant was found in 20 strains. It was carried by 14 E. cloacae and  three C. 
freundii and  K. pneumoniae strains, respectively, as shown in Table 1.  
3.5. Characterization of plasmids 
The size of plasmids ranged from 50 to 150 kb in donor strains. Transconjugants harboured 
only the large plasmid of 80 to 150 kb present also in the respective donor strain.  IncL/M was 
the dominant plasmid type identified in 31 isolates, followed by IncN and Inc A/C found in 21 
and 19 strains, respectively. FIIAs was observed in only one K. pneumoniae strain positive for 
VIM-1 and NDM-1, as shown in Table 1. Combination of IncA/C and IncN incompatibility 
group was noticed in 15 strains (13 E. cloacae and 2 K. pneumoniae), followed by 
combination of IncL/M and IncA/C which was present in five strains (three K. pneumoniae 
and one C. freundii). All C. freundii strains were positive for IncL/M with one strain, as 
mentioned, carrying also IncA/C type of plasmid. However, the association of plasmid 
incompatibility group with carbapenemase production was not confirmed. Thirty- four 
transconjugant strains were positive for VIM, NDM, OXA-48, CTX-M and TEM  β-
lactamases as their respective donors confirming plasmid location of carbapenemase genes. 
The trasconjugant strains harboured the same plasmid types as their respective donors.  
3.6. Genotyping 
Rep-PCR 
Unlike C. freundii and E. cloacae isolates K. pneumoniae showed pronounced diversity of 
their rep-PCR patterns. Eight isolates were classified into two clusters as shown in Figure 1a. 
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The cluster KI comprised strains 271 and 290 both belonging to ST 1574 while the second 
cluster KIV included strains 301 and 305 belonging to ST636. Four strains were singletons: 
86, 87, 17555 and 73. Five different STs were found: ST1574, ST859, ST15, S636, ST321 all 
associated with VIM-1 except of  ST37 associated with OXA-48.  
Sixteen C. freundii isolates subjected to genotyping were allocated into two clusters: one large 
CI with 11 isolates (88, 361, 347, 355, 273, 287, 95, 356, 348, 66, 195) all belonging to ST24 
and one small CIV with only two isolates (116 and 255) (Fig. 1b). Three isolates were 
singletons: 335, 337 and 363.  Two different ST were identified: ST24 linked to the large 
clone and ST8 found in a singleton strain 337.  
The E. cloacae isolates from Split showed different rep-PCR patterns compared to those from 
Zagreb. Eight different STs were observed: ST91, ST92, ST105, ST133, ST134, ST190, 
ST419 and ST418. ST418 which was associated with a small clone comprising three isolates 
from Zagreb positive for VIM-1 (281, 299 and 164), ST105 was associated with the large 
clone with 18 isolates from Zagreb positive for VIM-1 (strains 166, 168, 196, 104, 323, 237, 
181, 274, 89, 200, 204, 106, 149, 146, 213, 157, 186 and 372), and ST 92 comprising three 
isolates from Split positive for VIM-1 (6071, 20080 and 12488) and one from Zagreb (266). 
One E. cloacae isolate from Osijek (3294) had identical rep-PCR pattern as the strain from 
Zagreb (218) (Fig. 1c). It was obtained from the child that was previously hospitalized at the 
paediatric unit in University Hospital Centre Zagreb and thus it can be concluded that it was 
imported from Zagreb.  
 
4. Discussion 
 
Croatia is still a country with relatively low prevalence of carbapenem-resistant 
Enterobacteriaceae (CRE; approximately 1 %), compared to other Mediterranean countries 
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with up to 50% of CRE such as Greece or Cyprus (Canton et al., 2012).  The majority of our 
MBL-positive Enterobacteriaceae carried blaVIM-1 gene. The study demonstrated endemic 
occurrence of VIM-1 β-lactamase among CRE in University Hospital Zagreb. The first VIM-
1 entrobacterial isolate was E. coli from Greece reported in 2001 (Miriagou et al., 2003).  This 
type of MBL was previously associated with clonal outbreak in Split also in E. cloacae 
(Novak et al., 2014). The majority of VIM positive E. cloacae and K. pneumoniae isolates in 
our study harboured additional TEM-1 and CTX-M-15 β-lactamase that are usually carried on 
the same plasmid as blaVIM genes, whereas C. freundii isolates were positive for blaCMY genes 
which are chromosomally encoded in this species. In contrast to other European countries 
where K. pneumoniae was the dominant host harbouring VIM-1, in our study blaVIM-1 gene 
was carried predominantly by E. cloacae, followed by C. freundii. The majority of VIM-1 
strains originated from University Hospital Center Zagreb, but a few strains were obtained 
from University Hospital Split and University Hospital Osijek. The strain from Osijek was 
imported from Zagreb, due to patient transfer (Bedenić et al., 2015b). It had the same β-
lactamase content, rep-PCR pattern and PBRT as the strain from the same hospital unit in 
Zagreb. The VIM carrying E. cloacae strains from Split were not related to those from Zagreb 
suggesting that they arose as independent event. None of our VIM-producing K. pneumoniae 
strains belonged to the widespread ST 147 clone (Canton et al., 2012). However, the plasmids 
carrying blaVIM genes were similarily as in other European countries allocated most frequenty 
in IncA/C, IncL/M or IncN type plasmid.   
NDM-1 β-lactamase was identified in nine of our isolates. It originated from Indian 
subcontinent (Yong et al., 2009), but later spread in many European with UK being the most 
important reservoir of NDM positive CRE in Europe. The first NDM-1 positive isolate in 
Croatia was imported from Bosnia and Herzegovina in 2008 (Mazzariol et al., 2012) and was 
probably a representative of a Balkan clone. In our study K. pneumoniae was the dominant 
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species carrying the blaNDM-1 which is in concordance with the rest of Europe. K. pneumoniae 
isolates positive for NDM belonged to different STs not reported in other European countries 
but similarly as in other countries the plasmids probably carrying blaNDM genes belonged to 
IncA/C or IncL/M although we did not prove with certainty that these plasmids carried blaMBL 
genes.  
The study demonstrated emergence of OXA-48 β-lactamase in two hospital centers located in 
different geographic regions in Croatia. The strains displayed different rep-PCR patterns 
leading to conclusion that they occurred as independent events. OXA-48 was first report in 
Turkey in 2001 (Gulmez et al., 2008;  Aktas et al., 2008) but later spread in many European 
countries (Giani, 2012, O’Brien 2011) and also in Slovenia (Pirs et al., 2011) a country 
adjacent to Croatia. Croatia was spared from this type of carbapenemase until 2014.  OXA-
48-producing K. pneumoniae originating from hospital in Split belonged to ST37 unlike UK 
where it belonged to ST221 (Canton et al, 2012).  and the Netherland where it was allocated 
to ST636 (Kalpoe et al., 2011). ST37 was in our previous study associated with blaKPC-2 gene 
(Bedenić et al., 2012,a) indicating that different resistance markers can been acquired by the 
strains belonging to the same clone. Two E. cloacae isolates harbouring OXA-48 were 
assigned to ST 418 and showed identical rep-PCR patterns. They were both obtained from 
outpatients previously treated at the haematology unit of hospital in Zagreb in the same time 
period. Most of the OXA-48 positive strains in Western Europe were imported from Turkey, 
Morocco, Egypt, Algeria or Lybia (Canton et al., 2012). In our study there was no link to the 
endemic areas which leads to conclusion that blaOXA-48 genes arouse independently and were 
not imported from elsewhere. PCR for plasmid-incompatibility group was negative in all our 
strains while in other European studies they were associated with L/M, A/C, P or W type 
(Canton et al., 2012, Pfeifer et al, 2012) .  
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Interestingly, all C. freundii strains were found to be phenotypically positive for ESBLs but 
PCR did not reveal any tested ESBL gene. All were found to be positive for CMY β-
lactamases which are chromosomally encoded in this species although phenotypic tests for 
AmpC were negative. This could be due to low expression of blaCMY genes in C. freundii. 
Moreover, C. freundii was more uniform in plasmid content compared to other species with 
IncL/M being found in all strains. Genotyping of this species also revealed high level of 
relatedness demonstrated by both rep-PCR and MLST indicating that one clone was dominant 
in different hospital units during the study period in contrast to K. pneumoniae which showed 
high diversity of rep-PCR patterns, STs and plasmid incompatibility group suggesting that 
different strains and plasmids were involved in the spread of MBLs in this species.  
On the other hand six E. cloacae strains were phenotypically positive for AmpC but did not 
demonstrate any plasmid-mediated AmpC by PCR. This could be due to overexpression of 
chromosomal AmpC β-lactamase of E. cloacae. Sixty-three strains were positive for ESBL in 
inhibitor based test with clavulante but only 36 were positive for CTX-M-15. Other types of 
ESBLs belonging to TEM or SHV family were not found.  The rest of the strains had 
probably false positive ESBL test or had some rare type of ESBL which was not sought in this 
study. Laboratory detection of OXA-48 β-lactamase pose a serious problem because of low 
level carbapenem resistance and sometimes lack of additional ESBL. However, in our study 
all three strains had elevated carbapenem MICs and possessed additional CTX-M-15 β-
lactamase. Production of additional VIM-1 β-lactamase in two strains contributed to 
carbapenem resistance. Unfortunately, there is no inhibitor-based test for detection of OXA-
48 β-lactamase. Coproduction of VIM-1 and NDM-1 was found in seven strains. It was 
previously reported in Morocco (Barguigua A et al., 2013).  Combination of NDM-1 and 
OXA-48 was identified previously in India (Khajuria et al., 2014). In our study we found 
combination of VIM-1 with OXA-48. Laboratory detection of MBLs in Enterobacteriaceae 
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may also be difficult because of variable MICs of carbapenems. In our study even 8 strains 
had MIC of imipenem of 2 mg/L or lower and would be considered susceptible if EUCAST 
criteria were applied (http://www.eucast.org/).  Interestingly, the strains from heamatology 
unit were obtained mostly from stool as surveillance culture whereas the strains from medical 
ward and urology originated from urine and were associated with infection.  
Since the plasmids encoding carbapenemases often contain blaESBL, blaAmpC and qnr genes, 
we can assume that the therapeutic administration of carbapenems for the treatment of severe 
infections facilitates not only the spread of carbapenemases, but also ESBLs, plasmid-
mediated AmpC β-lactamases and fluoroquinolone resistance determinants leading to 
extensively drug resistant or pandrug resistant phenotype. Emergence of colistin resistance 
among carbapenemase-producing Enterobacteriaceae, as demonstrated in one study strain, is 
also worrying.  
Unfortunately, hospital hygiene measures and screening for faecal carriage did not prevent the 
spread of CRE in Croatian hospitals. Three different types of carbapenemases were identified 
showing the complexity of CRE in Croatia. The diversity of carbapenemases can be attributed 
to the several different introduction into the hospitals environment, their evolution during 
clonal dissemination, and transfer of plasmids. Similarly as in our first study VIM-1 was the 
dominant type of MBLs accompanied by sporadic occurrence of NDM-1 and the appearance 
of OXA-48 in 2013. blaVIM-1 genes were carried by variably transferable plasmids probably 
belonging to IncA/C or IncL/M with low frequency of conjugation in mating conditions 
applied in this study. However, we cannot prove with certainty that those plasmids carried 
carbapenemase genes.  In concordance with the previous study, the University Hospital 
Center Zagreb was shown to be the most important reservoir of CRE with predominance of a 
single E. cloacae clone carrying VIM-1 encoding gene together with CTX-M-15 and TEM-1 
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encoding genes. The E. cloacae isolates from Split were not clonally related to those from 
Zagreb but showed the same type of MBL (VIM-1) and the same class 1 integron structure.  
The fact that two strains coharboured VIM-1 and OXA-48 β-lactamase points out to amazing 
ability of Enterobacteriaceae to accumulate resistance genes as described previously (Chang 
et al., 2015) 
Early identification of class B and class D carbapenemases and isolation of carriers seem to be 
the mainstone of effective infection control strategy in the hospital setting which also prevents 
the propagation of this important resistance determinants into the community.  
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Figure legends 
Fig. 1.  
Rep-PCR dendrogram of study strains. Date of isolation and specimen type are shown. 
Similarity treshold of 97% was applied to define a clone (no difference in banding pattern).  
Fig. 1a. Rep-PCR dendrogram of K. pneumoniae isolates 
Fig. 1b. Rep-PCR dendrogram of C.freundii isolates 
Fig. 1c. Rep-PCR dendrogram of E. cloacae isolates 
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Table 1. Phenotypic tests, MICs, β-lactamase content, rep-PCR clusters, plasmid types and fluoroquinolone resistance genes of carbapenemase producing, 
Klebsiella spp. (Table 1a) , Citrobacter freundii (Table 1b) Enterobacter cloacae isolates (Table 1c).   
Abbreviations: ESBL-combined disk test using cephalosporins alone and combined with clavulanate for detection of ESBLs; AmpC-combined disk test 
using cephalosporins alone and combined with phenylboronic acid for detection of AmpC β-lactamases; MBL-combined disk test using carbapenems alone 
and combined with EDTA for detection of metallo-β-lactamases; IPM-imipenem; MEM-meropenem; ETP-ertapenem, GN-gentamicin; CIP-ciprofloxacin; 
COL-colistin; BL-β-lactamase; PBRT-PCR-based replicon type; ST- sequence type; NT-not tested 
Table 1a. Klebsiella spp 
 
 CENTRE AND ISOLATE NUMBER SPECIMEN DEPARTMENT DATE ESBL AMPC MBL IPM MEM ETP GN CIP COL BL 
REP PCR-
CLUSTER 
AND/OR 
ST 
PBRT Qnr 
1 SPLIT-4524 URINE HAEMATOLOGY 11.03.2013. + - + 8 8 16 16 0.5 0.12 SHV-1, TEM-1, CTX-M-15,, VIM-1 NT L/M NEG. 
2 ZAGREB-8399 (67) STOOL HEAMATOLOGY 15.01.2013. + - + 32 32 16 2 4 0.12 SHV-1, CTX-M-15,  VIM-1 NT NEG. NEG. 
3 ZAGREB-20157-1 (73) STOOL HAEMATOLOGY 01.02.2013. + - + 32 32 16 2 8 0.12 SHV-1, TEM-1, CTX-M-15,  VIM-1 KVI ST321 
L/M, 
A/C NEG. 
4 ZAGREB-40840 (86) SPUTUM MEDICAL 04.03.2013. + - + 8 16 4 4 32 0.25 SHV-1, TEM-1, CTX-M-15, VIM-1 KII ST859 L/M NEG. 
5 ZAGREB-40647 (87) STOOL HEAMATOLOGY 04.03.2013. + - + 1 4 32 16 8 0.25 SHV-1, TEM-1, CTX-M-15, VIM-1 
KIII 
ST15 NEG. NEG. 
6 ZAGREB-79559 (117) RECTAL SWAB MEDICAL 02.05.2013. - - + 8 16 16 16 32 1 SHV-1, VIM-1 NT NEG. NEG. 
7 ZAGREB-12762 (174) STOOL 
HAEMATOLOGY 
11.07.2013. + - + 4 8 8 64 32 0.25 SHV-1, TEM-1, CTX-M-15, NDM-1 NT N, A/C B 
8 ZAGREB-123327 (178) URINE 
UROLOGY 
16.07.2013. + - + 16 16 8 32 64 0.5 SHV-1, TEM-1, CTX-M-15, VIM-1 NT N, A/C NEG. 
9 ZAGREB-145846 (216) RECTAL SWAB MEDICAL 28.08.2013. - - + 4 8 32 32 32 0.5 SHV-11, TEM-1, NDM-1, VIM-1 NT FIIAS B 
10 ZAGREB-199305 (271) STOOL 
PAEDIATRIC 
HAEMATOLOGY 12. 11.2013. + - + 4 8 32 32 32 0.5 SHV-1, TEM-1,VIM-1 
KI 
ST1574 
L/M 
A/C B 
11 ZAGREB-208759 (279) SPUTUM MEDICAL ICU 12.12.2013. + - + 4 8 16 128 16 0.5 SHV-1, TEM-1, CTX-M-15, VIM-1 NT L/M NEG. 
12 ZAGREB-2494 -1(289) STOOL HEAMATOLOGY 07.01.2014 + + + 16 16 32 16 1 0.5 SHV-1, TEM-1, NDM-1, VIM-1 NT L/M A/C NEG. 
13 ZAGREB-2494 -2(290) STOOL HEAMATOLOGY 07.01.2014 + + + 16 16 32 16 1 0.5 SHV-1, TEM-1, NDM-1, VIM-1 KI ST1574 
L/M 
A/C NEG. 
14 ZAGREB-10536 (301) STOOL HEAMATOLOGY 21.01.2014. + - + 16 8 16 >128 64 0.25 SHV-1, TEM-1, NDM-1, VIM-1 KIV ST636 L/M NEG. 
15 ZAGREB-10536 ( 305) STOOL HEAMATOLOGY 21.01.2014. + - + 16 8 16 16 64 0.25 SHV-1, TEM-1, NDM-1, VIM-1 
KIV 
ST636 L/M NEG. 
16 SPLIT-17555 URINE MEDICAL 11.11.2014. + - - 32 32 32 32 16 0.12 SHV-11, TEM-1, CTX-M-15, OXA-48 KV ST37 NEG. NEG. 
 
Table 1b. Citrobacter freundii 
 CENTRE AND ISOLATE NUMBER SPECIMEN DEPARTMENT DATE ESBL AMPC MBL IPM MEM ETP GN CIP COL BL 
REP PCR-
CLUSTER 
AND/OR ST 
PBRT Qnr 
1 ZAGREB- 8767 (66) STOOL MEDICAL ICU 15.01.2013. + - + 2 4 8 64 >128 0.25 
TEM-1, CMY-4,  
VIM-1 CI L/M NEG. 
2 ZAGREB-20157-2 (74) STOOL HAEMATOLOGY 01.02.2013. + + + 32 32 16 2 8 0.12 TEM-1, CMY-4,  VIM-1 NT L/M. NEG. 
3 ZAGREB-41 613 (88) STOOL HEAMATOLOGY 05.03.2013. + - + 2 2 64 8 >128 0.25 
TEM-1, CMY-4,  
VIM-1 CI L/M NEG. 
4 ZAGREB-47402 (95) STOOL HEAMATOLOGY 13.03.2013 + - + 2 16 16 64 >128 0.25 
TEM-1, CMY-4,  
VIM-1 CI L/M B 
5 ZAGREB-81601 (118) 
BRONCHIAL 
CATHETER MEDICAL 06.05.2013. + - + 8 16 16 16 32 1 
CMY-2, 
NDM-1 NT L/M NEG. 
6 ZAGREB-8106 (116) STOOL 
PAEDIATRIC 
HEAMATOLOGY 30.04. 2013 + - + 8 16 16 16 64 1 
TEM-1, CMY-4,  
VIM-1 CIV L/M B 
7 ZAGREB-132452 (195) STOOL HEAMATOLOGY 01.08.2013. + - + 8 8 16 64 32 0.5 
TEM-1, CMY-4, 
NDM-1  VIM-1 
CI 
ST24 L/M NEG. 
8 ZAGREB-186879 (255) STOOL 
PAEDIATRIC 
HEAMATOLOGY 08.11.2013 + - + 4 2 32 1 1 0.5 
TEM-1, CMY-2,  
VIM-1 
CIV 
ST24 
L/M 
A/C B 
9 ZAGREB-207315 (273) URINE HEAMATOLOGY 10.12.2013 + - + 16 16 32 32 8 0.5 
TEM-1, CMY-4,  
VIM-1 CI L/M NEG. 
10 ZAGREB-217152 (287) STOOL HEAMATOLOGY 30.12.2013. + - + 4 16 32 64 1 0.5 TEM-1, CMY-4,  VIM-1 CI L/M NEG. 
11 ZAGREB-56767 (335) STOOL HEAMATOLOGY 08.04.2014. + - + 16 16 32 64 1 0.5 
TEM-1, CMY-4, 
VIM-1 
CII 
ST24 L/M NEG. 
12 ZAGREB-57576 (337) URINE MEDICAL 09.04.2014. + - + 16 16 32 32 1 0.5 TEM-1, CMY-4,  VIM-1 
CV 
ST8 L/M NEG. 
13 ZAGREB-81336 (347) STOOL HEAMATOLOGY 21.05.2014. + - + 16 16 32 >128 >128 0.25 
TEM-1, CMY-4,  
VIM-1 CI L/M NEG. 
14 ZAGREB-84809 (348) STOOL HEAMATOLOGY 27.05.2014. + - + 16 16 32 >128 0.06 0.12 
TEM-1, CMY-4,  
VIM-1 CI L/M NEG. 
15 ZAGREB-97934 (355) STOOL HEAMATOLOGY 17.06.201.4 + - + 4 16 32 >128 0.06 0.12 
TEM-1, CMY-4,  
VIM-1 CI L/M NEG. 
16 ZAGREB-97415 (356) STOOL HEAMATOLOGY 27.05.2014. + - + 4 16 32 32 >128 0.12 
TEM-1, CMY-4,  
VIM-1 CI L/M NEG. 
17 ZAGREB-104 881 (361) STOOL HEAMATOLOGY 01.07.2014. + - + 16 16 32 32 >128 0.12 TEM-1, CMY-4,  VIM-1 
CI 
ST24 L/M NEG. 
18 ZAGREB-105513 (363) STOOL HEAMATOLOGY 07.07.2014. + - + 16 16 32 32 >128 0.12 TEM-1, CMY-4,  VIM-1 CIII L/M NEG. 
 
 
 
 
 
 
 
 
Table 1c. Enterobacter cloacae 
 
 CENTRE AND ISOLATE NUMBER SPECIMEN DEPARTMENT DATE ESBL AmpC MBL IMI MEM ERT GM CIP COL BL 
REP PCR-
CLUSTER 
AND/OR ST 
PBRT Qnr 
1 SPLIT-2322 URINE MEDICAL ICU 16.02.2013 + - + 0.5 2 8 1 1 0.5 TEM-1, CTX-M-15, VIM-1 NT NEG. NEG. 
2 SPLIT-2417 URINE PSYCHIATRIC 19.02.2013. + - + 16 16 32 32 32 0.06 TEM-1, CTX-M-15, VIM-1 NT NEG. NEG. 
3 ZAGREB-45735 (89) URINE HEAMATOLOGY 11.03.2013. + - + 8 16 16 16 16 0.5 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 N, A/C NEG. 
4 ZAGREB-65063 (104) STOOL HEAMATOLOGY 10.04.2013 + - + 8 32 16 64 16 0.5 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 L/M, NEG. 
5 ZAGREB-68389 (106) STOOL HEAMATOLOGY 15.04.2013 + - + 8 16 16 4 32 1 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 N, A/C NEG. 
6 ZAGREB-96822 (146) URINE MEDICAL 31.05.2013. + - + 8 4 8 64 16 0.25 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 N, A/C NEG. 
7 ZAGREB-99954 (149) STOOL HAEMATOLOGY 05.06.2013. + - + 8 8 16 4 2 0.5 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 N, A/C NEG. 
8 ZAGREB-112243 (157) URINE MEDICAL 27.06.2013. + - + 8 4 8 64 16 0.25 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 N, A/C B 
9 ZAGREB-114449 (164) URINE MEDICAL 01.07.2013 + - + 16 16 8 32 >128 0.5 TEM-1. CTX-M-15, VIM-1 
EVI 
ST418 NT NEG. 
10 ZAGREB-17701 (166) URINE UROLOGY 05.07.2013. + - + 8 16 8 32 16 0.5 TEM-1, VIM-1 
EVII 
ST105 N, A/C B 
11 ZAGREB-117238 (168) URINE UROLOGY 05.07.2013. + - + 16 16 4 32 16 0.5 TEM-1, CTX-M-15, VIM-1 
EIV 
ST105 N, A/C B 
12 ZAGREB-120844 (175) 
THROAT 
SWAB HEAMATOLOGY 11.07.2013. + - + 8 4 2 32 64 0.5 TEM-1, CTX-M-15, VIM-1 NT N, A/C B 
13 ZAGREB-124076 (181) STOOL HEAMATOLOGY 17.07.2013. + - + 16 32 16 64 16 0.5 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 N B 
14 ZAGREB -128982 (186) STOOL HEAMATOLOGY 23.07.2013.. + - + 128 128 16 128 16 1 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 N, A/C B 
15 ZAGREB-133913 (196) URINE UROLOGY 06.08.2013. + + + 4 8 16 128 32 0.5 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 N, A/C NEG. 
16 ZAGREB-135007 (200) URINE HEAMATOLOGY 07.08.2013 + - + 4 32 16 32 16 0.12 TEM-1, CTX-M-15, VIM-1 EVII ST105 N, A/C B 
17 ZAGREB-138213 (204) STOOL HEAMATOLOGY 13.08.2013. + - + 128 128 16 >128 16 1 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 N, A/C B 
18 ZAGREB-143666 (213) BLOOD HEAMATOLOGY 25.08.2013 - - + 8 16 32 8 16 16 TEM-1, VIM-1 EVII ST105 N B 
19 OSIJEK-3294 BLOOD PAEDIATRIC HEAMATOLOGY 28.08.2013 - - + 1 1 0.25 >128 2 0.12 TEM-1, VIM-1 
EI 
ST91 N NEG. 
20 ZAGREB-147369 (218) BLOOD PAEDIATRC HEAMATOLOGY 31.08.2013 - - + 8 4 16 8 1 0.12 TEM-1, VIM-1 
EI 
ST91 N B 
21 ZAGREB-169731 (237) URINE HEMATOLOGY 09.10.2013. + - + 16 16 16 128 16 1 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 N NEG. 
22 ZAGREB-193444 (266) BLOOD 
NEUROLOGICAL 
ICU 19.11.2013 + + + 8 4 16 128 64 0.12 TEM-1, CTX-M-15, VIM-1, NDM-1 
EVII 
ST92 NEG. B 
23 ZAGREB-209029 (274) WOUND SWAB HEMATOLOGY 12.12. 2013. + - + 128 16 16 128 16 1 TEM-1, VIM-1 
EVII 
ST105 N B 
24 ZAGREB-208601 (276) URINE MEDICAL 12.12.2013. + - + 4 8 16 128 128 0.5 TEM-1, CTX-M-15, VIM-1 
EII 
ST133 NEG. NEG. 
25 ZAGREB-209377 (281) URINE OUTPATIENT 13. 12.2013. + - + 16 16 32 32 >128 0.5 TEM-1, CTX-M-15, VIM-1, OXA-48 
EV 
ST418 NEG. NEG. 
26 ZAGREB-211 765 (285) STOOL HEAMATOLOGY 17.12.2013 + - + 16 2 4 32 >128 0.5 TEM-1, VIM-1 EIII ST190 L/M NEG. 
27 ZAGREB-8391(299) URINE OUTPATIENT 17. 01.2014. + - + 16 16 32 32 16 0.25 TEM-1, CTX-M-15, VIM-1, OXA-48 EV ST418 NEG. NEG. 
28 ZAGREB-45120 (324) STOOL HEAMATOLOGY 19.03.2014. + - + 16 16 32 32 16 0.5 TEM-1, CTX-M-15, VIM-1 
EIII 
ST134 L/M B 
29 ZAGREB-46603 (325) BLOOD HEAMATOLOGY 21.03.2014. + - + 16 16 32 64 16 0.25 TEM-1, CTX-M-15, VIM-1 
EV 
ST419 L/M NEG. 
30 ZAGREB-45823 (323) NASAL SWAB HEAMATOLOGY 20.03.2014. + - + 128 128 16 128 16 1 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 N, A/C NEG. 
31 ZAGREB-127 998 (372) 
THROAT 
SWAB HAEMATOLOGY 13.08.2014. + + + 2 8 4 32 16 0.12 TEM-1, CTX-M-15, VIM-1 
EVII 
ST105 NEG. NEG. 
32 SPLIT-UR12488 URINE MEDICAL ICU 18.08.2014 + + + 32 32 4 64 32 0.12 TEM-1, CTX-M-15, VIM-1 EVIII ST92 NEG. NEG. 
33 SPLIT-HK6071 BLOOD SURGICAL ICU 06.08.2014. + + + 8 16 32 64 2 0.25 TEM-1, CTX-M-15, VIM-1 EVIII ST92 
A/C 
 NEG. 
34 SPLIT-UR20080 URINE MEDICAL 18.12.2014. + + + 2 8 4 32 16 0.12 VIM-1, DHA-1 EVIII ST92 NEG. B 
 
 
